Ernexa Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,510 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 251-275 of 1,000 matching filings.

Per page
25
Current page
11
4

FORM 4

Filing date
06 Jun 2022
Reporting date
03 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
01 Jun 2022
Reporting date
31 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
01 Jun 2022
Reporting date
26 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-11460

DEFA14A

Filing date
31 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-11460

NT 10-Q

Filing date
17 May 2022
Reporting date
31 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-264585

424B3

Filing date
12 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-264585

EFFECT filing

Filing date
11 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
06 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-264585

S-3

Filing date
29 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-11460

FORM DEFA14A

Filing date
26 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-11460

DEF 14A

Filing date
26 Apr 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 001-11460

NT 10-K

Filing date
01 Apr 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-438648

D filing

Filing date
23 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
17 Mar 2022
Reporting date
11 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
17 Mar 2022
Reporting date
11 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
17 Mar 2022
Reporting date
11 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
17 Mar 2022
Reporting date
11 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
17 Mar 2022
Reporting date
11 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .